The diagnostic utility of folate receptor autoantibodies in blood - PubMed

Abstract

Folate supplementation reduces the risk of neural tube defect (NTD) pregnancy, and folinic acid has been used to correct cerebral folate deficiency (CFD) in children with developmental disorders. In the absence of systemic folate deficiency, the discovery of autoantibodies (AuAbs) to folate receptor α (FRα) that block the uptake of folate offers one mechanism to explain the response to folate in these disorders. The association of FRα AuAbs with pregnancy-related complications, CFD syndrome, and autism spectrum disorders and response to folate therapy is highly suggestive of the involvement of these AuAbs in the disruption of brain development and function via folate pathways. The two types of antibodies identified in the serum of patients are blocking antibody and binding antibody. The two antibodies can be measured by the specific assays described and exert their pathological effects either by functional blocking of folate transport as previously shown or hypothetically by disrupting the FR by an antigen-antibody-mediated inflammatory response. We have identified both IgG and IgM AuAbs in these conditions. The predominant antibodies in women with NTD pregnancy belong to the IgG1 and IgG2 isotype and in CFD children, the IgG1 and IgG4 isotype. This review describes the methods used to measure these AuAbs, their binding characteristics, affinity, cross-reactivity, and potential mechanisms by which folate therapy could work. Because these AuAbs are associated with various pathologies during fetal and neonatal development, early detection and intervention could prevent or reverse the consequences of exposure to these AuAbs.

Similar articles

• Clinical recognition and aspects of the cerebral folate deficiency syndromes.

  Ramaekers V, Sequeira JM, Quadros EV. Ramaekers V, et al. Clin Chem Lab Med. 2013 Mar 1;51(3):497-511. doi: 10.1515/cclm-2012-0543. Clin Chem Lab Med. 2013. PMID: 23314536 Review.

• Folate receptor autoantibodies in pregnancy related complications.

  Shapira I, Sequeira JM, Quadros EV. Shapira I, et al. Birth Defects Res A Clin Mol Teratol. 2015 Dec;103(12):1028-30. doi: 10.1002/bdra.23436. Epub 2015 Sep 21. Birth Defects Res A Clin Mol Teratol. 2015. PMID: 26390016

• Genetic assessment and folate receptor autoantibodies in infantile-onset cerebral folate deficiency (CFD) syndrome.

  Ramaekers VT, Segers K, Sequeira JM, Koenig M, Van Maldergem L, Bours V, Kornak U, Quadros EV. Ramaekers VT, et al. Mol Genet Metab. 2018 May;124(1):87-93. doi: 10.1016/j.ymgme.2018.03.001. Epub 2018 Mar 3. Mol Genet Metab. 2018. PMID: 29661558

• Folinic acid treatment for schizophrenia associated with folate receptor autoantibodies.

  Ramaekers VT, Thöny B, Sequeira JM, Ansseau M, Philippe P, Boemer F, Bours V, Quadros EV. Ramaekers VT, et al. Mol Genet Metab. 2014 Dec;113(4):307-14. doi: 10.1016/j.ymgme.2014.10.002. Epub 2014 Oct 12. Mol Genet Metab. 2014. PMID: 25456743

• The metabolic basis for developmental disorders due to defective folate transport.

  Desai A, Sequeira JM, Quadros EV. Desai A, et al. Biochimie. 2016 Jul;126:31-42. doi: 10.1016/j.biochi.2016.02.012. Epub 2016 Feb 24. Biochimie. 2016. PMID: 26924398 Review.

Cited by

• Binding Folate Receptor Alpha Autoantibody Is a Biomarker for Leucovorin Treatment Response in Autism Spectrum Disorder.

  Frye RE, McCarty PJ, Werner BA, Scheck AC, Collins HL, Adelman SJ, Rossignol DA, Quadros EV. Frye RE, et al. J Pers Med. 2024 Jan 1;14(1):62. doi: 10.3390/jpm14010062. J Pers Med. 2024. PMID: 38248763 Free PMC article.

• Recent Advances in Folates and Autoantibodies against Folate Receptors in Early Pregnancy and Miscarriage.

  Qin XY, Ha SY, Chen L, Zhang T, Li MQ. Qin XY, et al. Nutrients. 2023 Nov 22;15(23):4882. doi: 10.3390/nu15234882. Nutrients. 2023. PMID: 38068740 Free PMC article. Review.

• Cerebral folate deficiency: A report of two affected siblings.

  Almahmoud R, Mekki M, El-Hattab AW. Almahmoud R, et al. Mol Genet Metab Rep. 2023 Apr 12;35:100975. doi: 10.1016/j.ymgmr.2023.100975. eCollection 2023 Jun. Mol Genet Metab Rep. 2023. PMID: 37101857 Free PMC article.

• Folate-dependent hypermobility syndrome: A proposed mechanism and diagnosis.

  Courseault J, Kingry C, Morrison V, Edstrom C, Morrell K, Jaubert L, Elia V, Bix G. Courseault J, et al. Heliyon. 2023 Apr 9;9(4):e15387. doi: 10.1016/j.heliyon.2023.e15387. eCollection 2023 Apr. Heliyon. 2023. PMID: 37095957 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • CORE
  • De Gruyter
  • ORBi (University of Liege)
  • Ovid Technologies, Inc.

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal